Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment

被引:125
|
作者
Palepu, A
Horton, NJ
Tibbetts, N
Meli, S
Samet, JH
机构
[1] Univ British Columbia, St Pauls Hosp, Dept Med, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V5Z 1M9, Canada
[2] DM STAT Inc, Medford, MA USA
[3] Boston Univ, Sch Med, Northampton, MA USA
[4] Boston Univ, Sch Publ Hlth, Northampton, MA USA
[5] Smith Coll, Dept Math, Northampton, MA 01063 USA
[6] Boston Univ, Dept Med, Gen Internal Med Sect, CARE Unit, Vancouver, WA USA
[7] Boston Univ, Dept Social & Behav Sci, Vancouver, WA USA
关键词
access; adherence; alcohol; antiretroviral therapy; HIV; substance abuse treatment; substance use;
D O I
10.1111/j.1360-0443.2003.00670.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aim We examined the association of substance abuse treatment with uptake, adherence and virological response to highly active antiretroviral therapy (HAART) among HIV-infected people with a history of alcohol problems. Design Prospective cohort study. Methods A standardized questionnaire was administered to 349 HIV-infected participants with a history of alcohol problems regarding demographics, substance use, use of substance abuse treatment and uptake of and adherence to HAART. These subjects were followed every 6 months for up to seven occasions. We defined substance abuse treatment services as any of the following in the past 6 months: 12 weeks in a half-way house or residential facility; 12 visits to a substance abuse counselor or mental health professional; or participation in any methadone maintenance program. Our outcome variables were uptake of antiretroviral therapy, 30-day self-reported adherence and HIV viral load suppression. Findings At baseline, 59% (205/349) of subjects were receiving HAART. Engagement in substance abuse treatment was independently associated with receiving antiretroviral therapy (adjusted OR; 95% CI: 1.70; 1.03-2.83). Substance abuse treatment was not associated with 30-day adherence or HIV viral load suppression. More depressive symptoms (0.48; 0.32-0.78) and use of drugs or alcohol in the previous 30 days (0.17; 0.11-0.28) were associated with worse 30-day adherence. HIV viral load suppression was positively associated with higher doses of antiretroviral medication (1.29; 1.15-1.45) and older age (1.04; 1.00-1.07) and negatively associated with use of drugs or alcohol in the previous 30 days (0.51; 0.33-0.78). Conclusion Substance abuse treatment was associated with receipt of HAART; however, it was not associated with adherence or HIV viral load suppression. Substance abuse treatment programs may provide an opportunity for HIV-infected people with alcohol or drug problems to openly address issues of HIV care including enhancing adherence to HAART.
引用
收藏
页码:361 / 368
页数:8
相关论文
共 50 条
  • [21] Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users
    Arnsten, JH
    Demas, PA
    Grant, RW
    Gourevitch, MN
    Farzodegan, H
    Howard, AA
    Schoenboum, EE
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 (05) : 377 - 381
  • [22] Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users
    Julia H. Arnsten
    Penelope A. Demas
    Richard W. Grant
    Marc N. Gourevitch
    Homayoon Farzadegan
    Andrea A. Howard
    Ellie E. Schoenbaum
    Journal of General Internal Medicine, 2002, 17 : 377 - 381
  • [23] Durable Viral Suppression Among People with HIV and Problem Substance Use in the Era of Universal Antiretroviral Treatment
    Paschen-Wolff, Margaret M.
    Campbell, Aimee N. C.
    Tross, Susan
    Choo, Tse-Hwei
    Pavlicova, Martina
    Braunstein, Sarah
    Lazar, Rachael
    Borges, Christine
    Castro, Michael
    Berg, Hayley
    Harriman, Graham
    Remien, Robert H.
    Des Jarlais, Don
    AIDS AND BEHAVIOR, 2022, 26 (02) : 385 - 396
  • [24] Improved HIV and Substance Abuse Treatment Outcomes for Released HIV-Infected Prisoners: The Impact of Buprenorphine Treatment
    Springer, Sandra Ann
    Chen, Shu
    Altice, Frederick L.
    JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2010, 87 (04): : 592 - 602
  • [25] Forgiveness and alcohol problems among people entering substance abuse treatment
    Webb, Jon R.
    Robinson, Elizabeth A. R.
    Brower, Kirk J.
    Zucker, Robert A.
    JOURNAL OF ADDICTIVE DISEASES, 2006, 25 (03) : 55 - 67
  • [26] Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
    Dean, GL
    Edwards, SG
    Ives, NJ
    Matthews, G
    Fox, EF
    Navaratne, L
    Fisher, M
    Taylor, GP
    Miller, R
    Taylor, CB
    de Ruiter, A
    Pozniak, AL
    AIDS, 2002, 16 (01) : 75 - 83
  • [27] Incarceration and Health Outcomes in HIV-Infected Patients: The Impact of Substance Use, Primary Care Engagement, and Antiretroviral Adherence
    Wang, Emily A.
    McGinnis, Kathleen A.
    Long, Jessica B.
    Akguen, Kathleen M.
    Edelman, E. Jennifer
    Rimland, David
    Wang, Karen H.
    Justice, Amy C.
    Fiellin, David A.
    AMERICAN JOURNAL ON ADDICTIONS, 2015, 24 (02): : 178 - 184
  • [28] Relationship between alcohol consumption, whether linked to other substance use or not, and antiretroviral treatment adherence in HIV plus patients
    Gonzalez-Alvarez, Sara
    Madoz-Gurpide, Agustin
    Parro-Torres, Carlos
    Hernandez-Huerta, Daniel
    Ochoa Mangado, Enriqueta
    ADICCIONES, 2019, 31 (01) : 8 - 17
  • [29] Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders
    Mellins, Claude Ann
    Havens, Jennifer F.
    McDonnell, Cheryl
    Lichtenstein, Carolyn
    Uldall, Karina
    Chesney, Margaret
    Santamaria, E. Karina
    Bell, James
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2009, 21 (02): : 168 - 177
  • [30] Substance Use Predictors of Poor Medication Adherence: The Role of Substance Use Coping Among HIV-Infected Patients in Opioid Dependence Treatment
    Gonzalez, Adam
    Mimiaga, Matthew J.
    Israel, Jared
    Bedoya, C. Andres
    Safren, Steven A.
    AIDS AND BEHAVIOR, 2013, 17 (01) : 168 - 173